![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 31, 23904-23910, August 4, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, December 9, 1999, and in revised form, April 20, 2000
The postsynaptic density protein PSD-95 and
related membrane-associated guanylate kinase (MAGUK) proteins assemble
signal transduction complexes at sites of cell-cell contact including synapses. Whereas PSD-95 and PSD-93 occur only at postsynaptic sites in
hippocampal neurons, SAP-102 also occurs in axons. In heterologous
cells, PSD-95 and PSD-93 mediate cell surface ion channel
clustering, but SAP-102 and SAP-97 do not. This selective ion channel
clustering activity by MAGUKs is explained by differential palmitoylation, as PSD-93 and PSD-95 are palmitoylated though SAP-97,
and SAP-102 are not. Rather than being palmitoylated, we find that
N-terminal cysteines from SAP-102 tightly bind to zinc. And, appending
the N terminus of SAP-102 to PSD-95 results in localization of the
chimera to both axons and dendrites. These data suggest that lipid
modifications and heavy metal associations with the N termini of MAGUKs
mediate differential functions and subcellular localizations of these
synaptic scaffolds.
Neurotransmission requires appropriate assembly of signal
transduction machinery at synaptic sites. Although mechanisms for organization of these synaptic signaling complexes are unclear, recent
studies suggest a general role for PDZ domain-containing membrane-associated guanylate kinases
(MAGUK)1 in receptor
clustering at pre- and postsynaptic sites (1-4).
Molecular cloning has identified four neuronal MAGUK proteins in
mammals: PSD-95 (SAP-90), PSD-93 (Chapsyn-110), SAP-97 (hDLG), and
SAP-102 (5-10). Immunohistochemical studies indicate that PSD-95 and
PSD-93 occur primarily in a somatodendritic distribution and are
specifically enriched at the PSD (11). Consistent with this
postsynaptic localization, targeted disruption of PSD-95 in mouse
disrupts N-methyl-D-aspartate
receptor-dependent synaptic plasticity (12). Recent studies
show that SAP-102 can be found at postsynaptic sites (7, 13). On the
other hand, SAP-97 occurs in presynaptic terminals in forebrain neurons
(8). Although SAP-97 knockout mice have not yet been reported, SAP-97
is the mammalian homologue of Drosophila discs large (DLG),
and flies lacking DLG show prominent presynaptic defects (14).
Mechanisms for differential localization and function of MAGUK proteins
remain uncertain. MAGUK proteins share extensive sequence homology in
their PDZ, SH3, and guanylate kinase domains. Significant differences
between these proteins occur primarily at their N termini, suggesting
roles for these regions in differential functions of these proteins.
Importantly, PSD-95 contains a pair of cysteine residues that are sites
for protein palmitoylation (15), a post-translational modification that
is essential for postsynaptic sorting (16). In contrast, SAP-97 lacks
N-terminal cysteines, and it is not palmitoylated. PSD-93 is
alternatively spliced at the N terminus to yield two major isoforms:
the first, which we now term PSD-93 Here, we report that both PSD-95 and PSD-93 occur prominently at
postsynaptic sites in hippocampal neurons, whereas SAP-102 localizes to
both dendrites and axons in these cells. Similarly, we find that PSD-95
and both isoforms of PSD-93 mediate surface ion channel clustering,
although SAP-97 and SAP-102 do not. Metabolic labeling studies show
that PSD-95 and both isoforms of PSD-93 are robustly palmitoylated and
that SAP-97 and SAP-102 are not. Mutants of PSD-95 and PSD-93 that
disrupt palmitoylation also block surface receptor clustering,
indicating a critical role for this lipid modification in ion channel
aggregation at the plasma membrane. Rather than being palmitoylated, we
find that N-terminal cysteines in SAP-102 tightly bind to zinc and that this unique N terminus of SAP-102 confers axonal targeting in addition
to postsynaptic sites within dendrites in neurons. These data suggest
that lipid modifications and heavy metal associations with the N
termini of MAGUKs mediate differential functions and subcellular
localizations of these synaptic scaffolds.
Antibodies and Immunoblotting--
The following primary
antibodies were used: rabbit polyclonal antibodies to Kv1.4 (17),
PSD-95 (9), PSD-93 (9), SAP-97 (15), SAP-102 (18) and monoclonal
antibodies to PSD-95 (#046; Affinity Bioreagents) and GFP (Quantum,
CLONTECH). GAD-65 antibody was a gift from Dr.
Steinunn Baekkeskov (Dept. of Medicine, UCSF). All antisera were
affinity-purified on columns containing the immunizing antigen linked
to Affi-Gel-10 resin. For immunoblotting, protein extracts were
resolved by SDS-PAGE and transferred to polyvinylidene difluoride
membranes. Primary antibodies were diluted in block solution containing
3% bovine serum albumin, 0.1% Tween 20 in Tris-buffered saline and
incubated with membranes overnight at 4 °C. Labeled bands were
visualized using ECL (Amersham Pharmacia Biotech).
cDNA Cloning and Mutagenesis--
Subcloning of wild-type,
mutant, and chimeric forms of PSD-93, SAP-97, and SAP-102 as N-terminal
fusions with GFP in pGW1 were analogous to those of PSD-95 previously
described (15, 16). Sequences of all polymerase chain reaction primers
are available upon request. Proper introduction of all mutations was verified by DNA sequencing.
Cell Transfection, Metabolic Labeling, and
Immunoprecipitation--
COS7 cells were grown in Dulbecco's modified
Eagle's medium containing 10% fetal bovine serum, penicillin, and
streptomycin. Cells were transfected using LipofectAMINE reagent
according to the manufacturer's protocol (Life Technologies, Inc.).
For studies of palmitoylation, transfected COS7 cells were labeled in
media containing 1 mCi/ml [3H]palmitic acid (50 Ci/mmol;
NEN Life Science Products). Cells were washed with ice-cold
phosphate-buffered saline and resuspended in 0.4 ml of lysis buffer
containing TEE (50 mM Tris-HCl, pH 7.4, 1 mM
EDTA, 1 mM EGTA), 150 mM NaCl, and 0.2% SDS.
After extracting for 20 min at 4 °C, Triton X-100 was added to 1%
to neutralize the SDS, and insoluble material was removed by
centrifugation at 10,000 × g for 10 min. For
immunoprecipitation experiments, the samples were then incubated with
GFP antibodies (1:150 dilution, CLONTECH) for
1 h at 4 °C. After the addition of 20 µl of protein A-Sepharose beads (Amersham Pharmacia Biotech), samples were incubated for 1 h at 4 °C. Immunoprecipitates were washed three times
with buffer containing TEE, 150 mM NaCl, and 1% Triton
X-100, boiled in SDS-PAGE sample buffer with 1 mM
dithiothreitol for 2 min, and analyzed by SDS-PAGE. For fluorography,
protein samples were separated by SDS-PAGE and stained with Coomassie
Blue. Gels were treated with Amplify (Amersham Pharmacia Biotech) for
30 min, dried under vacuum, and exposed to Hyperfilm-MP (Amersham
Pharmacia Biotech) at Transfection of Primary Neuronal Cultures and Immunofluorescent
Labeling--
Hippocampal cultures were transfected as described
previously (16). Briefly, acutely dissociated hippocampal neurons from E18 rats were transfected in suspension by lipid-mediated gene transfer. Cells were then plated at a density of 600/mm2 on
glass coverslips (Fisher) and maintained in Neurobasal media (Life
Technologies, Inc.) supplemented with B27. After washing with
phosphate-buffered saline containing 0.3% Triton X-100 3 times for 5 min each, the cells were incubated in phosphate-buffered saline/Tween
containing 3% normal goat serum for 1 h at room temperature to
block nonspecific antibody interactions. Primary antibodies were added
in block solution for 1 h at room temperature, followed by donkey
anti-mouse or goat anti-rabbit secondary antibodies conjugated to Cy2
or Cy3 fluorophores (diluted 1:200 in block solution) for 1 h at
room temperature. Coverslips were then mounted on slides (Frost Plus
slides; Fisher) with Fluoromount-G (Southern Biotechnology Associates,
Inc.), and images were taken under fluorescence microscopy with a 100×
oil immersion objective (numerical aperture = 1.4) affixed to a Leica
upright microscope.
Quantitative Measurement of GFP Expression--
Quantification
of polarized protein expression in dendrites versus axons
was performed on 10-15 neurons from 2-3 independent transfections.
Images of neurons were acquired with a CCD camera and quantitated using
Metamorph imaging software (Universal Imaging). The exposure time of
the camera was adjusted to limit photobleaching and so that maximum
pixel intensity was approximately one-half to three-fourths saturating
for cells with low to moderate expression levels, as determined by
total pixel counts. The average background fluorescence of
untransfected cells was subtracted. The degree of polarized expression
was determined by calculating the average pixel intensity in the axon
versus that in the dendrites. The average pixel intensity
was calculated through three dendrites and three sections of the axon
(each 20 µm in length). These averages were then converted into a
ratio of axonal versus dendritic expression. The data were
analyzed by paired t test.
Electron Microscopic Immunocytochemistry--
Adult Harlan
Sprague-Dawley rats were fixed by transcardial perfusion with an
aldehyde mixture consisting of 4% paraformaldehyde and 3% acrolein,
buffered with 0.1 M phosphate buffer, pH 7.4. Sodium
borohydride was used to terminate tissue fixation. Brain sections (40 µm) containing primary visual cortex were prepared using a Vibratome.
Sections were blocked in saline buffered with 0.01 M
phosphate (phosphate-buffered saline) containing 1% bovine serum
albumin. After an overnight incubation with affinity-purified anti-SAP-102 antibody (1 µg/ml), sections were processed for
immunolabeling with the avidin-biotin-horseradish peroxidase complex
using the ABC Elite kit (Vector) and 3,3'-diaminobenzidine (Aldrich)
and hydrogen peroxide as substrates (19). These sections were
post-fixed with 1% glutaraldehyde for 10 min, then with 1% osmium
tetroxide for 1 h, and stained as a whole with 4% uranyl acetate.
Sections were dehydrated for infiltration with the EMBED 812 resin (EM Sciences) for ultrathin sectioning. Sections (80 nm) were examined without lead citrate counterstaining.
UV Absorbance--
A GST fusion protein corresponding to amino
acids 1-118 of SAP-102 was expressed and purified from
Escherichia coli and dialyzed against 50 mM
Tris-HCl, pH 7.6. The SAP-102 N-terminal peptide, corresponding to
amino acids 1-20, was synthesized by Anaspec. The fully reduced
peptide was prepared by solubilizing in 0.1% trifluoroacetic acid,
reducing with 50 mM dithiothreitol at 90 °C for 30 min,
precipitating with 10% trichloroacetic acid at Circular Dichroism--
SAP102 1-20 peptide was prepared as
above. CD spectra were recorded on a Jasco J710 spectropolarimeter, and
each recording of peptide with ZnCl2 was corrected for the
spectrum of the corresponding concentration of ZnCl2
without peptide.
Differential Localization of PSD-95/93 and SAP-102 in
Neurons--
To characterize differential functions for the neuronal
MAGUK proteins, we compared their cellular distribution in primary hippocampal neuronal cultures. Low density neuronal cultures were maintained in neurobasal medium, and mature neurons at 2-3 weeks in
culture were analyzed by immunofluorescence. As previously reported
(11), PSD-95 and PSD-93 localize exclusively to small puncta that
correspond to synaptic sites (Fig. 1), as
they co-localize with synaptophysin (Ref. 11 and data not shown). These
synaptic puncta occur along dendritic processes (Fig. 1) that are
positive for the dendritic marker microtubule-associated protein-2
(MAP-2).
By contrast, SAP-102 shows a more diffuse localization in the
hippocampal neurons; it is present in the dendritic cytoplasm and is
modestly enriched at synapses (Fig. 1). Unlike PSD-95 and PSD-93,
SAP-102 also occurs in processes that are labeled by the axonal marker
neurofilament-H (Fig. 1). Axonal staining for SAP-102 is likely
specific as it is blocked by preadsorbing the antibody with the
immunizing antigen (data not shown). Furthermore, the affinity-purified
antibody used for staining recognizes only SAP-102 by Western blot
analysis of crude brain extracts (18).
SAP-102 Localizes to Presynaptic and Postsynaptic Sites in Cortical
Neurons--
To determine whether SAP-102 localizes to postsynaptic
and presynaptic sites in brain, we performed electron micrographic immunohistochemical staining of rat cerebral cortex using horseradish peroxidase-3,3' diaminobenzidine tetrahydrochloride as the label. Consistent with previous studies (7) we find that SAP-102 occurs at the
PSD of some cortical synapses (Fig. 2).
However, we find that SAP-102 also localizes to axons and is
particularly enriched at a subset of presynaptic terminals (Fig. 2).
These results are consistent with the observed dendritic and axonal
localizations of SAP-102 in cultured hippocampal neurons (Fig.
1).
Differential Neuronal Sorting of PSD-95 and SAP-102 Mediated by
Unique N-terminal Motifs--
PSD-95 and SAP-102 share highly
conserved PDZ, SH3, and GK domains, but each contains a unique N
terminus, suggesting possible roles for the N termini in differential
targeting of these proteins. To determine whether the N terminus of
SAP-102 regulates its differential localization, we transfected
hippocampal neurons with GFP fusion proteins and determined their
sorting to dendrites and axons by labeling transfected cells with MAP-2
and neurofilament-H antibodies (data not shown). We find that exogenous
PSD-95 is enriched in dendrites, whereas SAP-102 is present in both
dendrites and axons (Fig. 3,
A, B, and C). In the axons, SAP-102 shows diffuse
staining but is also enriched at presynaptic sites, where it
co-localizes in GABAergic neurons with the presynaptic marker GAD-65
(Fig. 3C; lower panels). Replacing the
palmitoylation motif of PSD-95 with the unique N terminus of SAP-102
mediates localization of the chimera to both axons and dendrites (Fig.
3, A and B) in a pattern similar to SAP-102.
These results indicate that the N terminus of SAP-102 may use a
different mechanism than that of PSD-95 to localize to postsynaptic
sites and to localize presynaptically.
Differential Palmitoylation of PSD-93/95 versus
SAP-97/102--
Recent studies demonstrate that N-terminal
palmitoylation of PSD-95 is necessary for postsynaptic targeting (16).
This raises the possibility that differential palmitoylation of the
MAGUK proteins accounts for the differential subcellular localization of these proteins. To address this, cells transfected with neuronal MAGUK proteins were metabolically labeled with
[3H]palmitate, and following immunoprecipitation and
SDS/PAGE, protein palmitoylation was detected by autoradiography. As
previously reported (15), we find that PSD-95 is robustly palmitoylated (Fig. 4). We also find that both isoforms
of PSD-93, the Palmitoylation Determines Differential Cell Surface Ion Channel
Clustering Activity of PSD-93/95 and SAP-97/102--
At postsynaptic
sites, certain MAGUK proteins cluster ion channels with downstream
protein networks (2, 4, 20). Some aspects of this clustering activity
can be reproduced in heterologous cell co-transfections. In this assay
co-transfection of PSD-95 with an interacting ion channel results in
co-localization of both proteins to surface patches on the plasma
membrane (17). To determine systematically which MAGUK proteins have
ion channel clustering activity in this assay we individually
co-transfected each of the neuronal MAGUKs with K+ channel
Kv1.4. When expressed alone, the neuronal MAGUKs or the K+
channel occur diffusely throughout the COS cells (Fig. 5). As previously reported (17), co-transfection of PSD-95 with Kv1.4 results
in surface clustering of both molecules (Fig. 5), whereas co-transfection of SAP-97 with Kv1.4 results in prominent perinuclear intracellular structures (21). Here we find that both isoforms of
PSD-93 (
To evaluate a role for protein palmitoylation in the differential cell
surface ion channel clustering activity of neuronal MAGUKs, we
transfected COS cells with various mutant and chimeric MAGUKs together
with Kv1.4. As previously reported (22), mutation of cysteines 3 and 5 of PSD-95 prevents ion channel clustering with Kv1.4. In
co-transfections with this palmitoylation-deficient isoform of PSD-95,
staining for both PSD-95 and Kv1.4 occurs along the nuclear membrane
and in large perinuclear structures (data not shown). Similarly,
co-transfections with palmitoylation-deficient forms of PSD-93 Zinc Binding Activity of the N Terminus of SAP-102--
It is
striking that SAP-102, which contains four N-terminal cysteines at
positions 7, 8, 11, and 13 is not palmitoylated and does not mediate
surface ion channel clustering. The presence of these cysteines in the
absence of palmitoylation suggests other important functions for this
unusual cluster of cysteines. Also conspicuous in the N terminus of
SAP-102 are 3 histidine residues at positions 2, 4, and 6. This
concentrated cluster of histidine and cysteine residues at the N
terminus suggests a possible role in heavy metal binding, as histidine
and cysteine residues often participate in metal ligation (23, 24). In
fact, the N-terminal sequence of SAP-102 bears considerable homology to
RING fingers and LIM domains, which both bind to zinc (24).
To evaluate possible zinc binding by SAP-102, we purified a GST fusion
protein containing the N-terminal 100 amino acids of SAP-102 from
E. coli. Optical absorption spectroscopy provided evidence
that this fusion protein binds zinc. The spectra obtained with reduced
SAP-102 and 0-50 µM ZnCl2 show that the
absorbency increases as Zn2+ is added (Fig.
7A). There is a maximum at
~240 nm in the difference spectra, indicating charge transfer
transitions between the metals and sulfur ligands. Our Zn2+
spectra are quite similar to those found for other protein-metal complexes such as those of zinc finger or metallothionein proteins (23,
25). No metal binding to GST alone, as evidenced by a spectral shift
with 1-10 µM ZnCl2, was detected (Fig.
7B).
To determine whether zinc binds to the unique cysteine-and
histidine-rich region, we evaluated binding to a synthetic 20-mer peptide corresponding to the extreme N terminus of SAP-102. Similar to
what was found with the fusion protein, we found that zinc addition
specifically induces a dramatic change in the absorbance spectrum with
an absorbance maximum at 240 nm (Fig. 7C). Difference ultraviolet absorption spectroscopy with 0.5 to 4.0 M
equivalents of ZnCl2 shows that binding occurs at a
stoichiometry of one Zn2+ per mole of SAP-102 peptide.
Circular dichroism studies demonstrate that zinc binding dramatically
alters the secondary structure of the N-terminal SAP-102 peptide. The
circular dichroism spectrum of the reduced apo-peptide displays a
minimum near 200 nm (Fig. 7D), which is expected for a
disordered polypeptide. The addition of ZnCl2 produces
marked changes in the spectrum, with an increase in the negative
ellipticity, consistent with gain of secondary structure. Again,
titration of the peptide showed a plateau at one molar equivalent of
added ZnCl2 (Fig. 7D).
This study demonstrates that the N termini of neuronal MAGUKs
determine in large part the differential cellular distribution and
neuronal functions for these proteins. PSD-93 and PSD-95 are robustly
palmitoylated, and both are enriched at postsynaptic sites in neurons
and mediate cell surface ion channel clustering in heterologous cells.
By contrast SAP-97 and SAP-102 are not modified by this lipidation also
occur in neuronal axons. The addition of the N terminus of SAP-102 to
PSD-95 enhances its axonal localization and accumulation at both
presynaptic and postsynaptic sites. The central role for palmitoylation
in surface ion channel clustering by MAGUKs is demonstrated by analysis
of chimeric constructs. Appending the N-terminal palmitoylation
consensus of PSD-95 or PSD-93 Considering that the palmitoylated N termini of PSD-95 and PSD-93 are
critical for protein function, it is interesting to note that PSD-93 is
alternatively spliced in this region (9). cDNA cloning from a rat
brain library identified four distinct N-terminal forms of PSD-93. The
two forms most commonly isolated, termed here PSD-93 Why might PSD-95 and PSD-93, two major components of the postsynaptic
density, be palmitoylated? As previous work has shown that this
modification is essential for postsynaptic targeting (16), it is
possible that palmitoylation functions primarily as a signal for
postsynaptic sorting. However, many postsynaptic proteins are not
palmitoylated, which suggests other functions for palmitoylation of
MAGUKs. Unlike other lipid modifications, palmitoylation is readily
reversible, and dynamic modulation of this lipidation may afford
plasticity (26). In non-neuronal cells, many palmitoylated proteins
occur together in caveolae, cholesterol-rich cave-like invaginations of
the plasma membrane (27). Whereas neurons lack anatomical caveolae and
lack the scaffolding protein caveolin, cholesterol-rich low density
membrane fractions have been isolated from brain (28). Palmitoylated PSD-95 and PSD-93 may be analogous to caveolin and function to assemble
signal transduction cascades at specialized lipid domains. Indeed
several intracellular enzymes that associate with the
PSD-95/N-methyl-D-aspartate receptor complex activity,
including Fyn (29) and neuronal nitric-oxide synthase (30), are found
in low density lipid compartments (31, 32).
Whereas PSD-95 and PSD-93 play critical roles in assembling signaling
machinery at the PSD, we find that SAP-102 also occurs in axons.
Insight into roles for MAGUK proteins in axons are suggested by the
phenotype of Drosophila dlg, a MAGUK of invertebrates (33). Discs large mutant flies show structural defects at the
postsynaptic neuromuscular junction (14) but also have presynaptic
defects, which include increased neurotransmitter release (14). Both the pre- and postsynaptic defects are rescued by presynaptic but not
postsynaptic expression of DLG (14). Furthermore, presynaptic expression of either SAP-97 or SAP-102 can rescue the phenotype of
dlg mutants (34).
Because SAP-102 contains N-terminal cysteines, it was surprising to
find that SAP-102 is not palmitoylated and does not mediate ion channel
clustering on the plasma membrane. Instead, we find that the N terminus
of SAP-102 contains a unique cysteine- and histidine-rich motif that
binds to zinc. This zinc binding is high affinity and saturable, such
that 1 mol of zinc binds/mol of SAP-102. Zinc binding to the N terminus
of SAP-102 is reminiscent of several other presynaptic proteins that
contain conserved zinc binding motifs including, RIM (35), rabphilin,
bassoon (36), and piccolo (37). These proteins, many of which contain
PDZ domains together with N-terminal zinc fingers, appear to regulate synaptic vesicle trafficking and fusion. It will now be important to
determine how the N-terminal zinc binding motif of SAP-102 regulates
both targeting and function at pre- and postsynaptic sites.
*
This work was supported by a pre-doctoral research grant
from the National Science Foundation and an Achievement Reward for College Scientists Foundation scholarship (to S. E. C.), a grant from
the American Heart Association (to J. L.-G.), and postdoctoral grants
from the Medical Research Council of Canada (to A. E. H.) and the
National Institutes of Health (NIH) (NICHD) and Spinal Cord Research
Foundation (to B. L. F). This research was also supported by NIH
Grant R01-NS36017 (to D. S. B.) and grants from the National Science
Foundation, the National Association for Research on Schizophrenia and
Depression, the EJLB, and the Culpeper and Beckman Foundations.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: University of
California School of Medicine, 513 Parnassus Ave., San Francisco, CA
94143-0444. Tel.: 415-476-6310; Fax: 415-476-4929; E-mail: bredt@itsa.ucsf.edu.
Published, JBC Papers in Press, April 21, 2000, DOI 10.1074/jbc.M909919199
The abbreviations used are:
MAGUK, membrane-associated guanylate kinase;
PSD, postsynaptic density;
dlg, discs large;
GFP, green fluorescent protein;
PDZ, postsynaptic
density-95, discs large, zonula occludens;
SAP, synapse-associated
protein;
GST, glutathione S-transferase;
MAP-2, microtubule-associated protein-2;
PAGE, polyacrylamide gel
electrophoresis.
Ion Channel Clustering by Membrane-associated Guanylate
Kinases
DIFFERENTIAL REGULATION BY N-TERMINAL LIPID AND METAL BINDING
MOTIFS*
,
,
,
,
,
¶
Departments of Physiology and University of
California, San Francisco, California 94143 and § Center
for Neural Science, New York University,
New York, New York 10013
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
, has cysteines at positions 5, 7, and 12; and the second, which we term PSD-93
, has cysteines at
positions 3 and 5, like PSD-95 (9). Finally SAP-102 has cysteines at
positions 7, 8, 10, and 13 (7). It is uncertain whether PSD-93 or
SAP-102 are palmitoylated and whether this regulates cellular
trafficking and ion channel clustering by these proteins.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
80 °C for 3 to 5 days.
20 °C for 15 min,
centrifuging at 14,000 × g for 5 min, and washing twice in ether. This reduced peptide was desiccated and stored at
70 °C until use. Immediately before use, the peptide was
resuspended (100 µM) in 50 mM Tris-HCl, pH
7.6, containing various concentrations of
ZnCl2, and spectra were recorded on a Cary 1E
UV-visible spectrophotometer. Difference spectra were calculated by
subtracting absorbance for peptide alone from absorbance for peptide
with ZnCl2.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (46K):
[in a new window]
Fig. 1.
Differential cellular distributions of
neuronal MAGUKs in hippocampal cultures detected by
immunofluorescence. PSD-95 (A, green) and PSD-93
(B, green) are found only at clusters that occur along MAP-2
(red)-positive dendritic processes. The small
panels on the right show enlargements of the boxed
regions on the left (yellow indicates regions in which
the red and green overlap). SAP-102 (C,
green) is also clustered along MAP-2
(red)-positive dendrites. D, these SAP-102
(green)-positive clusters are synaptic as they co-localize with
synaptophysin (red). E, SAP-102
(green) is also present in a dense network of axonal
processes that stain positively for neurofilament-H (NH,
red). Scale bar = 10 µm.

View larger version (143K):
[in a new window]
Fig. 2.
Localization of SAP-102 at presynaptic,
postsynaptic, and non-synaptic sites in cerebral cortex. Adult
cortical sections were immunolabeled using horseradish peroxidase-3,3'
diaminobenzidine tetrahydrochloride as the label. Four synapses are
shown in this panel, with arrows placed across
synaptic clefts in the pre-to-post-synaptic direction. Synapses 1 through 3 are all axo-spinous and asymmetric, indicating that they are
glutamatergic but differ in terms of SAP-102 distribution. SAP-102
occurs only postsynaptically at synapse 1, neither pre- nor
postsynaptically at synapse 2, and only pre-synaptically at synapse 3. Synapse 4 is symmetric, axo-dendritic, and probably GABAergic. Neither
side of this synapse is immunolabeled. In addition, the field shows two
more labeled axonal varicosities (la) and an unlabeled axon
varicosity (ua). Calibration bar = 500 nm.

View larger version (48K):
[in a new window]
Fig. 3.
Differential localization of SAP-102 and
PSD-95 in transfected hippocampal neurons mediated by N-terminal
motifs. A, appending the N-terminal region of SAP-102
to PSD-95 redistributes the chimera to axons and dendrites. Hippocampal
neurons were transfected with cDNAs encoding fusions of GFP tagged
to PSD-95, SAP-102, or a chimera of PSD-95 containing the N terminus of
SAP-102 (102/95). PSD-95 occurs primarily in dendrites, whereas both
SAP-102 and 102/95 are present in axons (arrows) and
dendrites. B, a bar graph summarizes expression
data for PSD-95, SAP-102, and 102/95 transfected into hippocampal
neurons. GFP signals were quantitated in axons and dendrites as
described under "Materials and Methods." Significant fluorescence
from SAP-102 and 102/95 is detected in axons (~65% that in
dendrites). In contrast, minimal PSD-95 fluorescence is detected in
axons (14%). Statistical analysis shows that the axon/dendrite
fluorescence densities for SAP-102 (p < 0.027) and
102/95 (p < 0.014) are significantly different from
PSD-95 but not from each other (p < 0.95).
C, SAP-102 localizes to presynaptic sites. A high power
fluorescence image of a hippocampal neuron transfected with GFP-SAP-102
shows the detailed localization of SAP-102 in the axon
(arrow) and dendrites. Arrowheads point at puncta
in the axon enriched for SAP-102. Bottom panels show that
SAP-102 (green)-positive axonal puncta co-localize with the
presynaptic marker GAD-65 (red) middle. The overlay of
SAP-102 and GAD-65 is shown at bottom right. Scale bar = 10 µm.
isoform, which has cysteines at positions 5 and 7, and the
isoform, which has cysteines at positions 3 and 5, are
robustly palmitoylated (Fig. 4). On the other hand SAP-97 and SAP-102
are not detectably palmitoylated (Fig. 4). Previous studies have shown
that mutations of cysteines 3 or 5 from PSD-95 disrupt palmitoylation
(15). Similarly, we find that mutating cysteine 5 or cysteine 7 of
PSD-93
to serine abolishes protein palmitoylation (Fig.
5 and data not shown).

View larger version (28K):
[in a new window]
Fig. 4.
Differential palmitoylation of neuronal
MAGUKs. A, sequence alignment of the N termini of
PSD-95, PSD-93
, PSD-93
, SAP-97, and SAP-102 (cysteine residues
are in bold) COS cells were transiently transfected with
PSD-95, PSD-93
(PSD-93C5, 7), PSD-93
(PSD-93C3, 5), SAP-97, or
SAP-102 fused to GFP and were metabolically labeled with
[3H]palmitate. Cells were lysed in radioimmune
precipitation buffer, and the solubilized material was
immunoprecipitated with an antibody to GFP. Immunoprecipitates were
loaded onto duplicate gels that were analyzed for
[3H]palmitate by fluorography (upper gel) or
were immunoblotted for GFP (lower gel). PSD-95 and both
isoforms of PSD-93 are palmitoylated, whereas SAP-97 and SAP-102 are
not. Mutating cysteine 5 of PSD-93
(PSD-93 C5S) to serine abolishes
palmitoylation, and mutation of cysteine 7 (PSD-93 C7S) dramatically
reduces palmitoylation.

View larger version (63K):
[in a new window]
Fig. 5.
PSD-95 and PSD-93 but not SAP-97 or SAP-102
can mediate cell surface ion channel clustering. COS cells were
co-transfected with Kv1.4 and each of the neuronal MAGUKs. Cells were
fixed 48 h post-transfection and double-labeled with antibodies to
the appropriate MAGUK (green) and Kv1.4 (red).
PSD-95 and both isoforms of PSD-93 co-cluster with Kv1.4, as evidenced
by formation of large irregular patches on the cell surface. By
contrast, SAP-97 and SAP-102 do not induce cell surface ion channel
clustering but rather form intracellular clusters that accumulate on
the nuclear membrane and in intracellular perinuclear structures.
Scale bar = 10 µm. A palmitoylation-deficient mutant
of PSD-93
PSD-93 (C5,7S) does not induce membrane ion channel
clustering but rather forms intracellular structures in a pattern
similar to SAP-97 and SAP-102. Scale bar = 10 µm.
and
) form membrane clusters with Kv1.4. On the other
hand, co-transfection of SAP-102 with the K+ channel
results in prominent co-localization on the nuclear membrane, and both
proteins also accumulate in large round structures in the cytoplasm in
a pattern similar to SAP-97 (Fig. 5). These data demonstrate that
postsynaptic MAGUKs, PSD-95, and PSD-93 can mediate plasma membrane
clustering of interacting ion channels, but the more diffusely
localized MAGUKs, SAP-97, and SAP-102 cannot. These results also show
that only palmitoylated MAGUKs are capable of clustering ion channels
on the plasma membrane.
(C5,7S) also show no clustering and yield prominent staining of the
nuclear membrane and of intracellular juxtanuclear spots (Fig. 5 and
data not shown). This pattern is similar to that observed in
co-transfections of Kv1.4 with wild-type SAP-97 or SAP-102. To further
establish a role for palmitoylation in cell surface channel clustering,
we evaluated chimeras in which the palmitoylated N termini of PSD-95 or
PSD-93
replaced the N terminus of SAP-97 or the palmitoylated N
terminus of PSD-93
replaced the N terminus of PSD-95. These
constructs, which induce palmitoylation of the chimeras, also mediate
cell surface clustering activity (Fig.
6). Kv1.4 does not co-cluster on the
plasma membrane with a chimera in which a cysteine mutant form of the
PSD-93
N terminus is fused to PSD-95 (Fig. 6).

View larger version (75K):
[in a new window]
Fig. 6.
Palmitoylation determines differential
surface ion channel clustering activity of PSD-93/95 and
SAP-97/102. COS cells were co-transfected with Kv1.4 and mutant
forms of SAP-97 or PSD-95. Cells were fixed 48 h post-transfection
and double-labeled with antibodies to SAP-97 or PSD-95
(green) and Kv1.4 (red). Kv1.4 co-clusters with
chimeras containing the N-terminal palmitoylation motif of PSD95 or
PSD-93
fused to SAP-97 (95:1-13/SAP-97 or PSD-93:1-17/SAP-97,
respectively) or the N-terminal domain of PSD-93
fused to PSD-95
(93:1-64/PSD-95). Kv1.4 does not co-cluster on the plasma membrane
with a chimera in which a cysteine mutant form of the PSD-93
N
terminus is fused PSD-95 (93:1-64 (C5, 7S)/PSD-95. Scale
bar = 10 µm.

View larger version (20K):
[in a new window]
Fig. 7.
Zinc binding to the N terminus of
SAP-102. A and B, ultraviolet absorption
spectra of SAP-102-GST or GST (160 µg/ml) with 0-10 µM
ZnCl2. C, ultraviolet absorption difference
spectra of reduced SAP-102 N-terminal peptide (100 µM)
with 50-400 µM added ZnCl2. D,
circular dichroism of SAP-102 N-terminal peptide (100 µM)
with 0-150 µM ZnCl2.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
onto SAP-97 induces ion channel
clustering on the plasma membrane.
and PSD-93
,
contain N-terminal cysteines, whereas the other two minor forms of
PSD-93 do not contain these cysteines (9). Furthermore, alternative
splicing of the PSD-93 N-terminal domains is tightly controlled in
a tissue-specific fashion (9). Because alternative N-terminal splicing
can alter ion channel clustering activity of MAGUK proteins, this may
provide an important mechanism for modulating synaptic assembly and plasticity.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Kennedy, M. B.
(1998)
Brain Res. Rev.
26,
243-257
2.
Sheng, M.,
and Wyszynski, M.
(1997)
Bioessays
19,
847-853
3.
O'Brien, R. J.,
Lau, L. F.,
and Huganir, R. L.
(1998)
Curr. Opin. Neurobiol.
8,
364-369
4.
Craven, S. E.,
and Bredt, D. S.
(1998)
Cell
93,
495-498
5.
Cho, K. O.,
Hunt, C. A.,
and Kennedy, M. B.
(1992)
Neuron
9,
929-942
6.
Kistner, U.,
Wenzel, B. M.,
Veh, R. W.,
Cases-Langhoff, C.,
Garner, A. M.,
Appeltauer, U.,
Voss, B.,
Gundelfinger, E. D.,
and Garner, C. C.
(1993)
J. Biol. Chem.
268,
4580-4583
7.
Muller, B. M.,
Kistner, U.,
Kindler, S.,
Chung, W. K.,
Kuhlendahl, S.,
Fenster, S. D.,
Lau, L.-F.,
Veh, R. W.,
Huganir, R. L.,
Gundelfinger, E. D.,
and Garner, C. C.
(1996)
Neuron
17,
255-265
8.
Muller, B. M.,
Kistner, U.,
Veh, R. W.,
Cases-Langhoff, C.,
Becker, B.,
Gundelfinger, E. D.,
and Garner, C. C.
(1995)
J. Neurosci.
15,
2354-2366
9.
Brenman, J. E.,
Christopherson, K. S.,
Craven, S. E.,
McGee, A. W.,
and Bredt, D. S.
(1996)
J. Neurosci.
16,
7407-7415
10.
Kim, E.,
Cho, K.-O.,
Rothschild, A.,
and Sheng, M.
(1996)
Neuron
17,
103-113
11.
Rao, A.,
Kim, E.,
Sheng, M.,
and Craig, A. M.
(1998)
J. Neurosci.
18,
1217-1229
12.
Migaud, M.,
Charlesworth, P.,
Dempster, M.,
Webster, L. C.,
Watabe, A. M.,
Makhinson, M.,
He, Y.,
Ramsay, M. F.,
Morris, R. G.,
Morrison, J. H.,
O'Dell, T. J.,
and Grant, S. G.
(1998)
Nature
396,
433-439
13.
Sans, N.,
Petralia, R. S.,
Wang, Y. X.,
Blahos, J., Jr.,
Hell, J. W.,
and Wenthold, R. J.
(2000)
J. Neurosci.
20,
1260-1271
14.
Budnik, V.,
Koh, Y. H.,
Guan, B.,
Hartmann, B.,
Hough, C.,
Woods, D.,
and Gorczyca, M.
(1996)
Neuron
17,
627-640
15.
Topinka, J. R.,
and Bredt, D. S.
(1998)
Neuron
20,
125-134
16.
Craven, S. E.,
El-Husseini, A. E.,
and Bredt, D. S.
(1999)
Neuron
22,
497-509
17.
Kim, E.,
Niethammer, M.,
Rothschild, A.,
Jan, Y. N.,
and Sheng, M.
(1995)
Nature
378,
85-88
18.
Firestein, B. L.,
Brenman, J. E.,
Aoki, C.,
Sanchez-Perez, A. M.,
El-Husseini, A. E.,
and Bredt, D. S.
(1999)
Neuron
24,
659-672
19.
Hsu, S. M.,
Raine, L.,
and Fanger, H.
(1981)
J. Histochem. Cytochem.
29,
577-580
20.
Kornau, H.-C.,
Seeburg, P. H.,
and Kennedy, M. B.
(1997)
Curr. Opin. Neurobiol.
7,
368-373
21.
Kim, E.,
and Sheng, M.
(1996)
Neuropharmacology
35,
993-1000
22.
Hsueh, Y. P.,
Kim, E.,
and Sheng, M.
(1997)
Neuron
18,
803-814
23.
Berg, J. M.
(1990)
Annu. Rev. Biophys. Biophys. Chem.
19,
405-421
24.
Schwabe, J. W.,
and Klug, A.
(1994)
Nat. Struct. Biol.
1,
345-349
25.
Vallee, B. L.,
and Auld, D. S.
(1995)
EXS (Basel)
73,
259-277
26.
Milligan, G.,
Parenti, M.,
and Magee, A. I.
(1995)
Trends Biochem. Sci.
20,
181-187
27.
Lisanti, M. P.,
Tang, Z.,
Scherer, P. E.,
Kubler, E.,
Koleske, A. J.,
and Sargiacomo, M.
(1995)
Mol. Membr. Biol.
12,
121-124
28.
Wu, C.,
Butz, S.,
Ying, Y.,
and Anderson, R. G. W.
(1997)
J. Biol. Chem.
272,
3554-3559
29.
Tezuka, T.,
Umemori, H.,
Akiyama, T.,
Nakanishi, S.,
and Yamamoto, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
435-440
30.
Brenman, J. E.,
Chao, D. S.,
Gee, S. H.,
McGee, A. W.,
Craven, S. E.,
Santillano, D. R.,
Huang, F.,
Xia, H.,
Peters, M. F.,
Froehner, S. C.,
and Bredt, D. S.
(1996)
Cell
84,
757-767
31.
Harder, T.,
Scheiffele, P.,
Verkade, P.,
and Simons, K.
(1998)
J. Cell Biol.
141,
929-942
32.
Keshet, G. I.,
Ovadia, H.,
Taraboulos, A.,
and Gabizon, R.
(1999)
J. Neurochem.
72,
1224-1231
33.
Woods, D. F.,
and Bryant, P. J.
(1991)
Cell
66,
451-464
34.
Thomas, U.,
Phannavong, B.,
Müller, B.,
Garner, C. C.,
and Gundelfinger, E. D.
(1997)
Mech. Dev.
62,
161-174
35.
Wang, Y.,
Okamoto, M.,
Schmitz, F.,
Hofmann, K.,
and Südhof, T. C.
(1997)
Nature
388,
593-598
36.
tom Dieck, S.,
Sanmartí-Vila, L.,
Langnaese, K.,
Richter, K.,
Kindler, S.,
Soyke, A.,
Wex, H.,
Smalla, K. H.,
Kämpf, U.,
Fränzer, J. T.,
Stumm, M.,
Garner, C. C.,
and Gundelfinger, E. D.
(1998)
J. Cell Biol.
142,
499-509
37.
Cases-Langhoff, C.,
Voss, B.,
Garner, A. M.,
Appeltauer, U.,
Takei, K.,
Kindler, S.,
Veh, R. W.,
De Camilli, P.,
Gundelfinger, E. D.,
and Garner, C. C.
(1996)
Eur. J. Cell Biol.
69,
214-23
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. Vandenberghe, R. A. Nicoll, and D. S. Bredt Interaction with the Unfolded Protein Response Reveals a Role for Stargazin in Biosynthetic AMPA Receptor Transport J. Neurosci., February 2, 2005; 25(5): 1095 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. N. Dong, E. A. Waxman, and D. R. Lynch Interactions of Postsynaptic Density-95 and the NMDA Receptor 2 Subunit Control Calpain-Mediated Cleavage of the NMDA Receptor J. Neurosci., December 8, 2004; 24(49): 11035 - 11045. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Leyland and C. Dart An Alternatively Spliced Isoform of PSD-93/Chapsyn 110 Binds to the Inwardly Rectifying Potassium Channel, Kir2.1 J. Biol. Chem., October 15, 2004; 279(42): 43427 - 43436. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Prange, T. P. Wong, K. Gerrow, Y. T. Wang, and A. El-Husseini A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin PNAS, September 21, 2004; 101(38): 13915 - 13920. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leonoudakis, L. R. Conti, S. Anderson, C. M. Radeke, L. M. M. McGuire, M. E. Adams, S. C. Froehner, J. R. Yates III, and C. A. Vandenberg Protein Trafficking and Anchoring Complexes Revealed by Proteomic Analysis of Inward Rectifier Potassium Channel (Kir2.x)-associated Proteins J. Biol. Chem., May 21, 2004; 279(21): 22331 - 22346. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nada, T. Shima, H. Yanai, H. Husi, S. G. N. Grant, M. Okada, and T. Akiyama Identification of PSD-93 as a Substrate for the Src Family Tyrosine Kinase Fyn J. Biol. Chem., November 28, 2003; 278(48): 47610 - 47621. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rumbaugh, G.-M. Sia, C. C. Garner, and R. L. Huganir Synapse-Associated Protein-97 Isoform-Specific Regulation of Surface AMPA Receptors and Synaptic Function in Cultured Neurons J. Neurosci., June 1, 2003; 23(11): 4567 - 4576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Townsend, A. Yoshii, M. Mishina, and M. Constantine-Paton Developmental loss of miniature N-methyl-D-aspartate receptor currents in NR2A knockout mice PNAS, February 4, 2003; 100(3): 1340 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Chetkovich, R. C. Bunn, S.-H. Kuo, Y. Kawasaki, M. Kohwi, and D. S. Bredt Postsynaptic Targeting of Alternative Postsynaptic Density-95 Isoforms by Distinct Mechanisms J. Neurosci., August 1, 2002; 22(15): 6415 - 6425. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. DeSouza, J. Fu, B. A. States, and E. B. Ziff Differential Palmitoylation Directs the AMPA Receptor-Binding Protein ABP to Spines or to Intracellular Clusters J. Neurosci., May 1, 2002; 22(9): 3493 - 3503. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, S. Fan, O. Makarova, S. Straight, and B. Margolis A Novel and Conserved Protein-Protein Interaction Domain of Mammalian Lin-2/CASK Binds and Recruits SAP97 to the Lateral Surface of Epithelia Mol. Cell. Biol., March 15, 2002; 22(6): 1778 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McLaughlin, R. Hale, D. Ellston, S. Gaudet, R. A. Lue, and A. Viel The Distribution and Function of Alternatively Spliced Insertions in hDlg J. Biol. Chem., February 15, 2002; 277(8): 6406 - 6412. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Firestein and C. Rongo DLG-1 Is a MAGUK Similar to SAP97 and Is Required for Adherens Junction Formation Mol. Biol. Cell, November 1, 2001; 12(11): 3465 - 3475. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sans, C. Racca, R. S. Petralia, Y.-X. Wang, J. McCallum, and R. J. Wenthold Synapse-Associated Protein 97 Selectively Associates with a Subset of AMPA Receptors Early in their Biosynthetic Pathway J. Neurosci., October 1, 2001; 21(19): 7506 - 7516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Martens, N. Sakamoto, S. A. Sullivan, T. D. Grobaski, and M. M. Tamkun Isoform-specific Localization of Voltage-gated K+ Channels to Distinct Lipid Raft Populations. TARGETING OF Kv1.5 TO CAVEOLAE J. Biol. Chem., March 9, 2001; 276(11): 8409 - 8414. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||